This website is made possible by third party financial support from Sage Therapeutics, Inc. and Biogen Inc.

This website is made possible by third party financial support from Sage Therapeutics, Inc. and Biogen Inc.

Editorial Board

Gisèle Apter, MD, PhD
Professor Child and Adolescent Pscyhiatry, University Rouen Normandy
Chief of the Department of Child and Adolescent Psychiatry, Groupe Hopsitalier Le Havre

Gisèle Apter is Professor and Chair of Child Psychiatry at the University of Rouen, Normandy, and Head of Infant and Child Psychiatry at Le Havre Hospital, Le Havre, France. She also directs a parent-infant psychiatric research laboratory. Gisèle studied general, child, and perinatal psychiatry, and infant psychology at the University Pierre et Marie Curie in Paris, followed by training in developmental psychology at the Children’s Hospital Harvard Medical School in Boston, USA. Gisèle is President of the Société de l'Information Psychiatrique (French Public Psychiatry). Her research and publications focus on infants of parents with personality disorder and the transmission of disorganized attachment and on the impact of maternal mental health on the developing infant. She is involved in many international projects, such as the Postpartum Depression: Action Towards Causes and Treatment (PACT) Consortium. She is currently the Representative for Western Europe at the World Psychiatric Association.

Michael Banov, MD
Assistant Clinical Professor, Psychiatry, Augusta University Health
Medical Director, Psych Atlanta Ketamine/Research Center

Dr. Michael Banov is a triple board-certified Adult, Adolescent, and Addiction Psychiatrist and is the medical director of Psych Atlanta and Psych Atlanta Research Center in Atlanta, Georgia. Psych Atlanta is an outpatient behavioral health group practice providing comprehensive outpatient services to those suffering from a wide range of psychiatric problems. Psych Atlanta Research Center works with pharmaceutical companies to test new compounds for the treatment of psychiatric disorders including, but not limited to, depression, anxiety, bipolar disorder, attention deficit disorder, and schizophrenia. Dr. Banov attended medical school at Emory School of Medicine and completed his psychiatry training at McLean-Mass General Hospital, Harvard Medical School residency program. He was chief resident of the psychotic disorders program and was given a teaching faculty appointment at Harvard Medical School before moving back to Georgia. He is a certified clinical investigator, having received his certification from the Association of Clinical Research Professionals (ARCP).He is also board certified as a Diplomate by the American Board of Integrative and Holistic Medicine. He is an assistant clinical professor of psychiatry at the Medical College of Georgia. Dr. Banov has conducted over 100 clinical research studies with new and existing compounds in the management of acute and chronic psychiatric conditions. He runs a treatment resistant mood and anxiety program that includes ketamine, Spravato, and other innovative therapy options.


Rakesh Jain, MD, MPH
Clinical Professor, Psychiatry
Texas Tech University School of Medicine

Dr. Jain attended medical school at the University of Calcutta in India and attended graduate school at the University of Texas School of Public Health in Houston, where he was awarded the National Institute/CDC Competitive Traineeship. He graduated from the School of Public Health in 1987 with a Master of Public Health degree. He completed a post-doctoral fellowship in research psychiatry with the Gerontology Center of the University of Texas Mental Sciences Institute in Houston, where he received a national research service award for the support of the postdoctoral fellowship. After this, he served a 3-year residency in psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston and completed 2 years of child and adolescent psychiatry fellowship. Dr. Jain is currently involved in multiple research projects studying the effects of medications on the short- and long-term treatment of depression, anxiety, pain/mood overlap disorders, and psychosis in adult and child/adolescent populations. He is also the author of several articles on the issue of mood and pain conditions. He was recently named Public Citizen of the Year by the National Association of Social Workers, Gulf Coast Chapter, in recognition of community and peer education and the championing of mental health issues.

Saundra Jain, MA, PsyD, LPC
Adjunct Clinical Affiliate, School of Nursing, The University of Texas
Co-founder, WILD 5 Wellness Program

Saundra Jain, MA, PsyD, LPC, is an Adjunct Clinical Affiliate, School of Nursing, at The University of Texas at Austin, and a psychotherapist in private practice. Dr. Jain is a co-creator of the WILD 5 Wellness Program and co-author of a well-received workbook written for those interested in improving their mentalwellness-KickStart30: A Proven 30-Day Mental Wellness Program. She is co-creator of the Psychedelics and Wellness Survey (PAWS) exploring the intersect between psychedelics and wellness. She serves as a member of the Psych Congress Steering Committee providing direction regarding educational gaps/needs for mental health practitioners, and Sana Symposium providing psychedelics education for mental health and addiction professionals.

Andrew Penn, MS, PMHNP
Associate Clinical Professor
University of California

Andrew Penn was trained as an adult nurse practitioner and psychiatric clinical nurse specialist at the University of California, San Francisco. He is board certified as an adult nurse practitioner and psychiatric nurse practitioner by the American Nurses Credentialing Center. Currently, he serves as an Associate Clinical Professor at the University of California-San Francisco School of Nursing. Mr. Penn is a psychiatric nurse practitioner with Kaiser Permanente in Redwood City, California, where he provides psychopharmacological treatment for adult patients and specializes in the treatment of affective disorders and PTSD. He is a former board member of the American Psychiatric Nurses Association, California Chapter, and has presented nationally on improving medication adherence, emerging drugs of abuse, treatment-resistant depression, diagnosis and treatment of bipolar disorder, and the art and science of psychopharmacologic practice.